Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bioadaptives Inc (OP: BDPT )

0.0900 -0.0089 (-9.00%)
Streaming Delayed Price Updated: 3:35 PM EST, Feb 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,501
Open 0.1188
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0989
Today's Range 0.0900 - 0.1188
52wk Range 0.0001 - 0.1500
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioMedNewsBreaks – BioAdaptives Inc. (BDPT) Announces Board Appointment of UFC Senior Executive Reed Harris
Via Investor Brand Network
BioMedNewsBreaks — BioAdaptives Inc. (BDPT) Announces Board Appointment of Visionary Leader Mark Frissora
Via Investor Brand Network

Performance

YTD
-21.74%
-21.74%
1 Month
-35.71%
-35.71%
3 Month
-24.94%
-24.94%
6 Month
+14900.00%
+14900.00%
1 Year
+14900.00%
+14900.00%

More News

Read More
BioMedNewsBreaks — BioAdaptives Inc. (BDPT) Announces Dividend for Common Stock Shareholders
Via Investor Brand Network
BioMedNewsBreaks – BioAdaptives Inc. (BDPT) Launches Xcellara(TM) — an Innovative Supplement That Harnesses Nature for Optimal Health
Via Investor Brand Network
InvestorNewsBreaks — BioAdaptives Inc. (BDPT) Announces One-for-One Stock Dividend
Via Investor Brand Network
BioMedNewsBreaks — BioAdaptives Inc. (BDPT) to Proceed with Human Clinical Trial for Zeranovia(TM)
Via Investor Brand Network
BioMedNewsBreaks – BioAdaptives Inc. (BDPT) Unveils New Suite of Next-Gen Nutritional Products
Via Investor Brand Network
InvestorNewsBreaks – BioAdaptives, Inc. (BDPT) Appoints Car Rental Industry Veteran to Its Board of Directors
Via Investor Brand Network
BioAdaptives, Inc. Appoints James Keener as New CEO to Lead Strategic Growth Initiatives
Via NewMediaWire
BioAdaptives, Inc. Appoints James Keener as New CEO to Lead Strategic Growth Initiatives
Via TheNewswire.com
BioAdaptives, Inc. Announces NaturaComplete, an All-In-One Supplement to Optimize Its AI-Based FYO Obesity Management System
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
BioAdaptives Announces Low-Cost AI FYO Smartphone App Tracking System to Detect Unwanted Muscle Mass Loss Reported With Obesity Management
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
BioAdaptives Announces Low-Cost AI FYO Smartphone App Tracking System to Detect Unwanted Muscle Mass Loss Reported With Obesity Management
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence
BioAdaptives' Subsidiary, Livestock Impact, Inc., Celebrates Banner 2023 Equine Championship Titles Attributed to Its Advanced Proprietary Supplement Products
Via NewMediaWire
Topics Retirement
Exposures Pension
BioAdaptives' Subsidiary, Livestock Impact, Inc., Celebrates Banner 2023 Equine Championship Titles Attributed to Its Advanced Proprietary Supplement Products
Via TheNewswire.com
Topics Retirement
Exposures Pension
BioAdaptives Announces Signing of a New Distributors Agreement for AI Body Composition Measuring App and New Weight Management System
Via NewMediaWire
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Livestock Impact, Inc., Subsidiary of BioAdaptives, Inc., Launches Innovative Food Lab for Development of Treats and Supplement Powder for Human, Equine, and Canine Products
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
BioAdaptives, Inc. to Form New Division, AI BodyShape Lab, to Promote Adult Fitness and Weight Management
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
BioAdaptives, Inc. Introduces PROTEINnMORETM Ahead of 2024 Launch of AI-based "Fit Your Outfit" app
Via NewMediaWire
BioAdaptives Announces Special Holiday Wellness Offers and Gift
Via NewMediaWire
BioAdaptives Announces the Development of VeganHepPlusTM Liver Supplement Formula
Via NewMediaWire
BioAdaptives Highlights Continued Success of Popular LUNG ARMOR System as US Enters Flu Season
Via NewMediaWire
Exposures COVID-19
BioAdaptives Takes Aim at Safe Pain Management with All-Natural Supplement
Via NewMediaWire
BioAdaptives Targets Multi-Billion Dollar Sleep Market with SleepEZ Natural Supplement
Via NewMediaWire
BioAdaptives, Inc. Celebrates Nine Years of Commercial Success in Equine Nutrition
Via NewMediaWire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.